Home
    • Plans Blog Contact
    Ascend Wellness Holdings, Inc. logo

    Ascend Wellness Holdings, Inc.

    AAWH
    Last price US$0.411
    Market cap US$84.2m
    12M price change -35.78%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Zoetis IncZTS Industry peer Amphastar PAMPH Industry peer Prestige Consumer HealthcarePBH Industry peer IQVIA Holdings IncIQV Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Ascend Wellness Holdings, Inc. Overview

    Industry: Drug Manufacturers Specialty & Generic

    Sector: Healthcare

    Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. It owns, operates, and manages cannabis cultivation facilities and dispensaries in several states across the United States, including Illinois, Massachusetts, Michigan, Ohio, New Jersey, and Pennsylvania. The company's cannabis product categories include flowers, pre-rolls, concentrates, vapes, edibles, and other cannabis-related products. The company also sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in New York, New York. Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. It owns, operates, and manages cannabis cultivation facilities and dispensaries in several states across the United States, including Illinois, Massachusetts, Michigan, Ohio, Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Ascend Wellness Holdings, Inc. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Aug 12, 2026

    Quarterly result summary

    Revenue was $126.1M (+8% YoY). Net loss was -$9.8M (from $29.5M). Adjusted EBITDA was $29.1M.

    Revenue $126.1M +8% YoY
    Net loss -$9.8M from $29.5M
    Adjusted EBITDA $29.1M reported
    Cash $67M reported

    What changed

    • Revenue +8% YoY to $126.1M.
    • Net loss was -$9.8M (from $29.5M).

    Guidance / outlook

    we expect this trend to continue in the quarters ahead,” said Roman Nemchenko, Chief Financial Officer.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Aug 12, 2026 SEC filing 8-K Aug 12, 2026 SEC filing 10-Q May 13, 2026 SEC filing 8-K May 13, 2026 Earnings release Earnings release May 13, 2026 SEC filing 10-K Mar 12, 2026 SEC filing 8-K Mar 12, 2026 Earnings release Earnings release Mar 12, 2026 SEC filing 8-K Feb 09, 2026 Earnings release Earnings release Feb 09, 2026 SEC filing 10-Q Nov 10, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 3.00/5
    Ascend Wellness Holdings, Inc. boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Return on Equity

    Score 0.43/5
    Ascend Wellness Holdings, Inc. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Ascend Welln... AAWH US$84.2m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 1.96/5
    Ascend Wellness Holdings, Inc. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Ascend Welln... AAWH US$84.2m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Leverage

    Score 1.11/5
    Ascend Wellness Holdings, Inc. registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
    Ascend Welln... AAWH US$84.2m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Reported currency
    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Ascend Wellness Holdings, Inc. logo

    Ascend Wellness Holdings, Inc.

    US$0.411

    US$84.2m

    1.48%

    -35.78%